Max N. Wallace is Director at Humacyte, Inc. (HUMA). They have made 1 open-market trade across 1 company since 2024, most recently 2024-05-20.
CIK 0001877453
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $50K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HUMA | 4,015 | $2K |
Shares reported on the most recent Form 4, priced at the 2024-05-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HUMA | BUY | 2024-05-20 | 2024-05-21 | $6.25 | $50K | +4.8% | -25.5% | -10.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.